MacroGenics
MGNX
#9393
Rank
NZ$0.15 B
Marketcap
NZ$2.37
Share price
-0.72%
Change (1 day)
-58.85%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.15 Billion

As of December 2025 MacroGenics has a market cap of NZ$0.15 Billion. This makes MacroGenics the world's 9393th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.15 B-58.27%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of MacroGenics was reported to be:

NZ$0.15 Billion
by Nasdaq info icon info icon
NZ$0.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
NZ$2.13 B 1,325.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$256.18 B 170,672.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$431.15 B 287,307.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$260.36 B 173,455.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$307.49 B 204,874.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.567 T 1,044,967.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$183.77 B 122,401.03%๐Ÿ‡บ๐Ÿ‡ธ USA